Schedule 13G ownership disclosure
Immunome Inc
Security class unavailable · CUSIP: 45257U108
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,762,013
- Percent of class
- 9.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-24-001987
- Form type
- SC 13G
- Filer
- Immunome Inc.
- CIK
- CIK 1472012
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership